Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors

These findings suggest that prevalence of TMB-H varies widely depending on tumor type and TMB-H does not appear to be a factor associated with OS among patients across these cancer types treated in the absence of immunotherapy.